Market Overview

Benzinga's M&A Chatter for Monday January 5, 2015

Share:
Benzinga's M&A Chatter for Monday January 5, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday January 5, 2015

Sources Say NPS Pharmaceuticals Seeking Buyer

The Rumor:
Shares of NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) surged higher Monday, on a report from Dow Jones that the biopharmaceutical company is seeking a buyer and has hired Goldman Sachs as an advisor. According to sources, a sale could bring $4.5 million.

Back in June 2014, NPS was rumored to be a target of Shire plc (NASDAQ: SHPG).

A spokesperson for NPS Pharmaceuticals declined comment on the rumor. A Shire spokesperson did not immediately respond to a request for comment.

NPS Pharmaceuticals shares closed Monday at $38.15, a gain of 6.5%.

NeuLion to Acquire DivX for $62.5M

The Deal:
NeuLion, Inc. (OTC: NEUL) has agreed to acquire DivX for approximately $62.5 million, consisting of $37.5 million in shares of NeuLion common stock and a $25 million two-year convertible note, subject to working capital adjustments.

The deal is expected to close in Q1 of calendar 2015.

Ingersoll Rand Acquires Assets Of Cameron's Centrifugal Compression Division for $850M

The Deal:
Ingersoll-Rand plc (NYSE: IR) announced Monday it has completed the acquisition of the assets of Cameron International Corporation's (NYSE: CAM) Centrifugal Compression division for $850 million. The deal was completed on January 1, 2015.

Ingersoll Rand shares closed Monday at $62.16, a loss of $1.10.

Facebook Acquires Wit.ai

The Deal:
Speech recognition software company wit.ai, confirmed on its blog Monday, that it has been acquired by Facebook, Inc. (NASDAQ: FB). Terms were not disclosed.

Faceboook shares closed Monday at $77.19, a loss of $1.26.

Posted-In: M&A News Rumors Movers

 

Related Articles (CAM + FB)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Monday's After-Hours Market Movers

Mast Therapeutics Reports Update on Epic Study Enrollment, Offers '15 Milestones